FDA Import Refusal SCS-5604185-2/11/1 — ANA MARIA LONDO?O PALACIO
The FDA refused shipment SCS-5604185-2/11/1 from ANA MARIA LONDO?O PALACIO (Colombia) on Aug 26, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Aug 26, 2024
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75